|Articles|May 21, 2019

I-ACT for Children Selects Advarra as Central IRB

Advarra has announced that it has been selected by the Institute for Advanced Clinical Trials for Children to provide central institutional review board services to the organization’s pediatric clinical trial site network. I-ACT for Children currently includes 44 U.S. pediatric research sites.

For further details, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

I-ACT for Children Selects Advarra as Central IRB

Related Content

Recruitment in the Age of AI: Q&A with John Worden, Javara

What It Actually Means to Embed the Patient Voice in Trial Design

ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization

From Participation to Understanding: Reframing Engagement in Clinical Trials

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

Trending on Applied Clinical Trials Online

What It Actually Means to Embed the Patient Voice in Trial Design

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis